Brief: Aptus Pharma Enters Urology Therapy Segment
21/11/2025 14:38
Nov 21 (Reuters) - Aptus Pharma Ltd APTM.BO: APTUS PHARMA LTD - ENTERS UROLOGY THERAPY SEGMENT Source text: ID:nBSE458P5G Further company coverage: APTM.BO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptus Pharma
See all newsBrief: Aptus Pharma Approves Proposal To Raise 448.8 Million Rupees
Brief: Aptus Pharma Ltd Approves Bonus Issue In 3:2 Ratio
Brief: Aptus Pharma Recommends Issue Of Bonus Equity Shares In Ratio Of 3:2
Brief: Aptus Pharma To Consider Bonus Shares
Brief: Aptus Pharma Expands Into Life-Saving Injectables And ICU Care